Protein leverage hypothesis

From WikiMD's WELLNESSPEDIA

Protein leverage hypothesis is a theory in nutritional biology that suggests organisms prioritize the intake of protein over other macronutrients. This hypothesis was proposed by Simpson and Raubenheimer in 2005. According to this hypothesis, when the proportion of protein in the diet is low, organisms tend to overeat fats, carbohydrates, or both in order to reach the target protein intake. This overconsumption of non-protein energy is thought to contribute to obesity.

Overview[edit]

The Protein leverage hypothesis is based on the idea that protein is a vital nutrient for survival and reproduction, and that organisms have evolved mechanisms to ensure adequate protein intake. This includes the ability to regulate food intake in response to the protein content of the diet. When the protein content of the diet is low, organisms are driven to eat more in an attempt to reach their protein target. This can lead to overconsumption of energy and weight gain, contributing to the obesity epidemic.

Evidence[edit]

Several lines of evidence support the protein leverage hypothesis. Experimental studies in insects, fish, birds, and mammals, including humans, have shown that organisms tend to overeat when the protein content of the diet is low. Epidemiological studies have also found a negative correlation between dietary protein percentage and total energy intake in humans. Furthermore, a number of studies have shown that increasing the protein content of the diet can reduce energy intake and promote weight loss.

Criticism[edit]

Despite the evidence supporting the protein leverage hypothesis, it has been criticized on several grounds. Some argue that the evidence is not strong enough to support the hypothesis, while others suggest that other factors, such as the palatability of food and the availability of cheap, energy-dense foods, may also play a role in overeating and obesity.

See also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.